Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
If youre struggling with a plateau, consider consulting with a concierge physician to develop a customized weight management plan that incorporates advanced metabolic therapies
In the SUSTAIN FORTE clinical trials, participants in the semaglutide (Ozempic) group showed an average reduction of 2.2 percentage points in the HbA1c levels with a 2 mg weekly dosage and 1.9 percentage points with a 1 mg weekly dosage of semaglutide after 40 weeks
The studies included analyzes of clinical records and real-world databases tracking patients taking Novo Nordisks NOVOb.CO Wegovy or Ozempic, Eli Lillys LLY.N Zepbound or Mounjaro, or older GLP-1 treatments
Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist developed by Eli Lilly
US$ 27.71
US$ 22.11
US$ 20.72
